Ironwood (IRWD) | Financial Analysis & Statements
Ironwood Pharmaceuticals Inc. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
47.7M
Operating Income
6.6M
13.74%
Net Income
-2.3M
-4.77%
EPS (Diluted)
$-0.01
Balance Sheet Metrics
Total Assets
396.9M
Total Liabilities
658.7M
Shareholders Equity
-261.8M
Cash Flow Metrics
Operating Cash Flow
73.8M
Free Cash Flow
74.6M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Ironwood Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 296.2M | 351.4M | 442.7M | 410.6M | 413.8M |
| Cost of Goods Sold | - | - | - | 0 | 0 |
| Gross Profit | - | - | - | 410.6M | 413.8M |
| Gross Margin % | 0.0% | 0.0% | 0.0% | 100.0% | 100.0% |
| Operating Expenses | |||||
| Research & Development | 95.1M | 111.4M | 116.1M | 44.3M | 70.4M |
| Selling, General & Administrative | 82.3M | 144.3M | 158.3M | 116.0M | 111.1M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 177.4M | 255.7M | 274.4M | 160.3M | 181.5M |
| Operating Income | 118.8M | 95.7M | 168.3M | 250.3M | 232.2M |
| Operating Margin % | 40.1% | 27.2% | 38.0% | 61.0% | 56.1% |
| Non-Operating Items | |||||
| Interest Income | 4.1M | 4.5M | 19.0M | 9.5M | 726.0K |
| Interest Expense | 32.7M | 33.0M | 21.6M | 7.6M | 31.2M |
| Other Non-Operating Income | -20.1M | -2.0M | -1.1B | 182.0K | -1.1M |
| Pre-tax Income | 70.0M | 65.2M | -948.1M | 252.4M | 200.7M |
| Income Tax | 46.0M | 64.3M | 83.5M | 77.4M | -327.8M |
| Effective Tax Rate % | 65.7% | 98.7% | 0.0% | 30.6% | -163.4% |
| Net Income | 24.0M | 880.0K | -1.0B | 175.1M | 528.4M |
| Net Margin % | 8.1% | 0.3% | -233.0% | 42.6% | 127.7% |
| Key Metrics | |||||
| EBITDA | 124.9M | 102.8M | 188.9M | 261.2M | 234.4M |
| EPS (Basic) | $0.15 | $0.01 | $-6.45 | $1.13 | $3.26 |
| EPS (Diluted) | $0.15 | $0.01 | $-6.45 | $0.96 | $3.21 |
| Basic Shares Outstanding | 161842000 | 159083000 | 155435000 | 154366000 | 162245000 |
| Diluted Shares Outstanding | 161842000 | 159083000 | 155435000 | 154366000 | 162245000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Ironwood Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 215.5M | 88.6M | 92.2M | 656.2M | 620.1M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 46.7M | 81.9M | 129.1M | 115.5M | 114.0M |
| Inventory | - | - | - | - | - |
| Other Current Assets | 12.0M | 11.9M | 12.0M | 7.7M | 8.7M |
| Total Current Assets | 274.2M | 182.4M | 233.3M | 780.6M | 745.2M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 9.3M | 11.0M | 13.9M | 15.4M | 16.7M |
| Goodwill | 2.0M | 2.9M | 3.7M | 0 | - |
| Intangible Assets | 2.0M | 2.9M | 3.7M | - | - |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 107.9M | 150.2M | 215.9M | 299.6M | 358.8M |
| Total Non-Current Assets | 122.7M | 168.5M | 237.8M | 319.9M | 381.7M |
| Total Assets | 396.9M | 350.9M | 471.1M | 1.1B | 1.1B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 2.9M | 2.1M | 7.8M | 483.0K | 935.0K |
| Short-term Debt | 202.9M | 3.2M | 202.7M | 3.1M | 120.0M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 9.4M | 4.4M | 8.8M | 3.6M | 4.8M |
| Total Current Liabilities | 242.2M | 38.8M | 276.1M | 25.5M | 161.7M |
| Non-Current Liabilities | |||||
| Long-term Debt | 394.9M | 596.3M | 512.9M | 412.8M | 355.8M |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | 21.6M | 17.1M | 28.4M | 9.8M | 3.5M |
| Total Non-Current Liabilities | 416.5M | 613.4M | 541.3M | 422.6M | 359.3M |
| Total Liabilities | 658.7M | 652.2M | 817.4M | 448.1M | 521.0M |
| Equity | |||||
| Common Stock | 163.0K | 160.0K | 156.0K | 154.0K | 162.0K |
| Retained Earnings | -1.7B | -1.7B | -1.7B | -696.4M | -937.6M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | -261.8M | -301.3M | -346.3M | 652.4M | 605.9M |
| Key Metrics | |||||
| Total Debt | 597.8M | 599.5M | 715.5M | 415.9M | 475.8M |
| Working Capital | 32.0M | 143.5M | -42.8M | 755.1M | 583.5M |
Balance Sheet Composition
Ironwood Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 24.0M | 880.0K | -1.0B | 175.1M | 528.4M |
| Depreciation & Amortization | 1.9M | 2.0M | 1.6M | 1.4M | 1.5M |
| Stock-Based Compensation | 17.2M | 29.8M | 32.0M | 27.0M | 22.3M |
| Working Capital Changes | 45.1M | 15.3M | 12.9M | 10.2M | 3.1M |
| Operating Cash Flow | 130.7M | 118.0M | 185.1M | 281.4M | 246.0M |
| Investing Activities | |||||
| Capital Expenditures | -34.0K | -142.0K | -273.0K | -136.0K | -265.0K |
| Acquisitions | - | 0 | -1.0B | 0 | 0 |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -34.0K | -142.0K | -1.0B | -136.0K | -265.0K |
| Financing Activities | |||||
| Share Repurchases | - | 0 | 0 | -126.4M | -24.1M |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 0 | 150.0M | 400.0M | 0 | 0 |
| Debt Repayment | 0 | -265.0M | -100.0M | -120.7M | 0 |
| Financing Cash Flow | 0 | -118.0M | 270.8M | -247.1M | -24.1M |
| Free Cash Flow | 127.0M | 103.4M | 183.2M | 273.6M | 261.6M |
| Net Change in Cash | 130.7M | -90.0K | -570.4M | 34.1M | 221.6M |
Cash Flow Trend
Ironwood Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
27.13
Forward P/E
2.79
Price to Book
-2.34
Price to Sales
2.24
PEG Ratio
-0.18
Profitability Ratios
Profit Margin
8.11%
Operating Margin
13.74%
Return on Equity
-9.17%
Return on Assets
19.85%
Financial Health
Current Ratio
1.13
Debt to Equity
-2.28
Beta
0.17
Per Share Data
EPS (TTM)
$0.15
Book Value per Share
$-1.61
Revenue per Share
$1.83
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| IRWD | 618.0M | 27.13 | -2.34 | -9.17% | 8.11% | -2.28 |
| Zoetis | 49.8B | 19.58 | 15.04 | 65.99% | 28.24% | 279.59 |
| Haleon Plc - ADR | 42.4B | 18.72 | 1.88 | 10.27% | 15.11% | 52.37 |
| Dynavax Technologies | 1.8B | 54.60 | 3.41 | -7.14% | -13.13% | 54.15 |
| Ani Pharmaceuticals | 1.8B | 24.08 | 3.10 | 16.16% | 8.87% | 116.19 |
| Perrigo Company plc | 1.6B | 2,818.00 | 0.55 | -38.66% | -33.51% | 131.16 |
Financial data is updated regularly. All figures are in the company's reporting currency.






